期刊文献+

非甾体抗炎药肠损伤大鼠模型小肠组织中蛋白酶激活受体2的表达与肥大细胞分布 被引量:1

Relationship of protease.activated receptor-2 and mast cell in the rat model of small intestinal mucosal damage by short-term administration of non-steroidal anti-inflammatory drug
原文传递
导出
摘要 目的观察蛋白酶激活受体2(PAR-2)和肥大细胞在双氯芬酸致小肠黏膜损伤大鼠模型小肠组织中的表达、分布及意义。方法随机数字表法将24只成年雄性sD大鼠随机分为空白对照组和模型组,每组12只,空白对照组按1ml/250g蒸馏水灌胃1次,模型组给予7.5mg·kg^-1·d^-1双氯芬酸灌胃1次,至第5天行腹腔注射麻醉,取末端回肠,采用甲苯胺蓝染色法测定小肠黏膜中肥大细胞的分布,并对肥大细胞进行计数;采用免疫组织化学、Western印迹、荧光定量PCR分析PAR-2在小肠黏膜组织中的定位、表达和mRNA的变化。结果模型组小肠黏膜肥大细胞数明显高于空白对照组(10.3±2.2比4.2±1.2,P〈0.05)。免疫组织化学结果显示PAR-2表达于黏膜表面上皮、隐窝上皮和固有层炎性细胞,阳性染色位于细胞质。模型组小肠黏膜中PAR-2mRNA表达高于空白对照组(2.63±0.26比1,P〈0.05),PAR-2蛋白表达高于空白对照组(24.3±2.4比17.5±3.5,P〈0.05)。结论PAR-2、肥大细胞参与了双氯芬酸致大鼠小肠黏膜损伤过程。PAR-2可能由肥大细胞分泌的类胰蛋白酶激活而参与非甾体抗炎药致小肠损伤的发病过程。 Objective To identify the expression and significance of protease-activated receptor-2 (PAR-2) and mast cell (MC) in the rat model of small intestinal mucosal damage by a short-term administration of dielofenac. Methods Twenty-four SD-rats were divided into 2 groups ( control group and model group, 12 rats each ) by random digit table. The rats in the control group were treated with 1 ml distilled water per 250 g, once a day while those in the model group diclofenac 7.5 mg/kg per day. Their terminal ileum was harvested at Day 5 after an intraperitoneal injection. Toluidine blue dyeing was employed to determine the distribution of MC and its count in intestinal mucous membrane, hnmunohistochemistry, Western blot and real-time PCR (polymerase chain reaction) were employed analyze the location, expression and change of PAR-2 mRNA in intestinal mucous membrane. Results The count of MC was obviously higher in the model group than that in the control group(10. 3±2.2 vs 4. 2±1.2, P 〈0. 05). PAR-2 was expressed on the mucous surface, recesses epidermis and lamina propria inflammatory cells. And positive dyes were located within cytoplasm. As compared with the control group, the expression of PAR-2 mRNA was higher( 2. 63±0. 26 vs 1, P 〈 0. 05 )and its protein expression higher in the model group( 24. 3±2. 4 vs 17.5±3.5, P 〈 0. 05 ). Conclusion Both PAR-2 and mast cell are involved in the pathogenesis of small intestinal mucosa injury induced by diclofenac in rats. PAR-2 may be activated by tryptase released from mast cells and participate in the pathogenesis of small intestinal injury as induced by non-steroidal anti-inflammatory drugs.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第21期1502-1505,共4页 National Medical Journal of China
关键词 受体 蛋白酶激活 肥大细胞 小肠 抗炎药 非甾类 Receptor, protease-activated Mast cells Intestine, small Anti-inflammatory agent, non-steroidal
  • 相关文献

参考文献16

  • 1Jacob C,Yang PC,Darmoul D,et al.Mast cell tryptase controls paracellular permeability of the intestine.J Biol chem,2005,31936-31948.
  • 2张烁,吕宾,姒健敏,陈方明,孟立娜,吴伟峰,俞蕾敏.非甾体消炎药对大鼠小肠黏膜机械屏障功能的影响[J].中华内科杂志,2009,48(1):44-47. 被引量:10
  • 3Okayama T,Yoshida N,Uchiyama K,et al.Mast cell are involved in the pathogenesis of indomethacin-induced rat enteritis.J Gastroenterology,2009,44:35-39.
  • 4Reuter BK,Asfaha S,Buret A,et al.Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.J Clin Invest,1996,98:2076-2085.
  • 5Chiu CJ,McArdle AH,Brown R,et al.Intestinal mucosal lesion in low-flow states:I.A morphological,hemodynamic,and metabolic reappraisal.Arch Surg,1970,101:478483.
  • 6Cattaruzza F,Cenac N,Barocelli E,et al.Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents.Am J Pathol,2006,169:177-188.
  • 7Bjarnason I,Hayllar J,Macpherson AJ,et al.Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine.Castroenterol,1993,104:1832-1847.
  • 8Laine L,Connors LG,Reicin A,et al.Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.Gastroenterol,2003,124:288-292.
  • 9Allison MC.Howatson AC,Torrance CJ,et al.Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs.N Engl J Med,1992,327:749-754.
  • 10Bjarnason I,Price AB,Zanelli G,et al.Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures.Gastroenterology,1988,94:1070-1074.

二级参考文献7

  • 1Cappell MS, Schein JR. Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicity. Gastroenterol Clin North Am, 2000, 29:97-124.
  • 2Guth PH, Aures D, Paulsen G. Topical aspirin plus HC1 gastric lesions in rats. Cytoprotective effect of prostaglandin, cimetidine, and probanthine. Gastroenterology, 1979, 76:88-93.
  • 3Butzner JD, Pamar R, Bell CJ, et al. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut, 1996, 38:568-573.
  • 4Chin CJ, Meardle AH, Brown R, et al. Intestinal mueosal lesions in low flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg,1970, 101:478-483.
  • 5Kurata JH, Nogawa AN, Noritake D. NSAIDs increase risk of gastrointestinal bleeding in primary care patients with dyspepsia. J Fam Pract, 1997,45:227-235.
  • 6Brzozowski T, Konturek PC,Konturek SJ,et al. Gastric adaptation to injury by repeated doses of aspirin strengthens mucosal defence against subsequent exposure to various strong irritants in rats. Gut, 1995,37:749-757.
  • 7Thiefin G, Beaugerie L. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. Joint Bone Spine,2005, 72:286-294.

共引文献9

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部